Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide Homeostasis
由于一氧化氮稳态破坏导致储存血液中的储存损伤
基本信息
- 批准号:8901566
- 负责人:
- 金额:$ 4.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-18 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAcuteAdhesivesAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAutologousBindingBiochemicalBiological AvailabilityBloodBlood BanksBlood PlateletsBlood TransfusionBlood VesselsBlood flowCanis familiarisCell CommunicationCellsChronic DiseaseClinicalCollaborationsComputer SimulationCritical IllnessDataDevelopmentElectron Spin Resonance SpectroscopyEndothelial CellsEndotheliumErythrocyte TransfusionErythrocytesFDA approvedFoundationsFunctional disorderFundingGoalsHealthHemoglobinHemolysisHomeostasisHumanIn VitroInflammationInflammatoryInflammatory ResponseInjuryIronIsotope LabelingIsotopesLaboratoriesLengthLesionMeasuresMediatingMetabolismMethodologyMitochondriaModelingMolecular BiologyMusMyographyNitratesNitric OxideNitric Oxide SynthaseNitritesNitrogenOperative Surgical ProceduresOrganOutcomePathway interactionsPatientsPlatelet ActivationPneumoniaPreparationProceduresProdrugsProductionProtocols documentationPublicationsReactive Oxygen SpeciesRequest for ApplicationsRiskRoleSafetySeveritiesSignal TransductionSignaling MoleculeStaphylococcus aureusStreamSystemSystemic infectionTestingTherapeuticTimeTransfusionTranslationsUnited States National Institutes of HealthVasodilationagedbody systemglycosylated-nitric oxide complex hemoglobin Ahuman dataimprovedin vivoinsightmouse modelnoveloxidant stresspre-clinicalresearch studyresponse to injurystemtoolvascular endothelial dysfunctionvolunteer
项目摘要
DESCRIPTION (provided by applicant): The overall goal of this project is to improve the safety and efficacy of transfusion of stored blood. There is good evidence that red blood cell storage results in loss of functionality and integrity of red blood cells over time and that this contributes to deleterious effects upon blood transfusion. This project, which is a competitive renewal of a previously funded one, is built around the hypothesis that this storage lesion is largely due to dysregulation of nitric oxide homeostasis in the blood. This disruption is due to increased nitric oxide scavenging by cell-free hemoglobin and microparticles that are released during hemolysis in stored blood and diminished nitric oxide production by the newly discovered red cell nitric oxide synthase. In this renewal we will examine the exact mechanisms of loss of NO bioavailability, as well as down-stream effects of this loss, particularly platelet activation. e will also study interactions that occur in a susceptible host receiving the transfusion. A vast array of clinical, biophysical, molecular biology, and biochemical tools will be applied to characterize the nitric oxide storage lesion in vitro in stored blood as well as in chimeric mice models, a canine model, and in human studies. In addition, therapeutics will be explored in these systems that could restore nitric oxide homeostasis by increasing nitric oxide production.
描述(由申请人提供):该项目的总体目标是提高储存血液输血的安全性和功效。有充分的证据表明,红细胞储存会导致红细胞的功能丧失和完整性,这会导致对输血的有害影响。该项目是对先前资助的项目的竞争更新,它围绕以下假设:该储存病变主要是由于血液中一氧化氮稳态的失调。这种破坏是由于一氧化氮通过无细胞的血红蛋白和微粒清除,这些氧化物在溶血期间释放的储存血液中释放出来,并通过新发现的红色细胞一氧化氮合酶减少一氧化氮的产生。在这种续约中,我们将研究无生物利用度丧失的确切机制,以及这种损失的下流效应,尤其是血小板激活。 E还将研究接受输血的易感宿主中发生的相互作用。将应用大量的临床,生物物理,分子生物学和生化工具来表征储存的血液以及嵌合小鼠模型,犬类模型以及人类研究中的一氧化氮储存病变。此外,将在这些系统中探索治疗剂,这些系统可以通过增加一氧化氮的产生来恢复一氧化氮的稳态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark T Gladwin其他文献
1172-74 Pulmonary hypertension is strongly associated with mortality in sickle cell disease: Comparison of echocardiographic outcome predictors
- DOI:
10.1016/s0735-1097(04)91779-2 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Yukitaka Shizukuda;Vandana Sachdev;Inez Ernst;James S Nichols;Maria Jison;Bernice Brown;William Blackwelder;Griffin P Rodgers;Oswaldo Castro;Frederick P Ognibene;Jonathan P Plehn;Mark T Gladwin - 通讯作者:
Mark T Gladwin
15 - Carbonic Anhydrase Mediated Nitrite Bioactivation
- DOI:
10.1016/j.freeradbiomed.2014.10.501 - 发表时间:
2014-11-01 - 期刊:
- 影响因子:
- 作者:
Nadeem Wajih;Jun Wang;Xiaohua Liu;Christian Keggi;Amber Lee;Andrea M Belanger;Courtney Sparacino-Watkins;Mark T Gladwin;Daniel B Kim-Shapiro - 通讯作者:
Daniel B Kim-Shapiro
Sodium Nitrite Enhances Pulmonary Epithelial Cells Wound Healing Under Normoxia via Cyclic GMPindependent Signaling Pathways
- DOI:
10.1016/j.freeradbiomed.2010.10.276 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Ling Wang;Mark T Gladwin - 通讯作者:
Mark T Gladwin
Mark T Gladwin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark T Gladwin', 18)}}的其他基金
Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE
镰状细胞病和心血管风险 - 红细胞交换 SCD-CARRE
- 批准号:
10653703 - 财政年份:2022
- 资助金额:
$ 4.96万 - 项目类别:
1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
1/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10402364 - 财政年份:2019
- 资助金额:
$ 4.96万 - 项目类别:
1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
1/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10165800 - 财政年份:2019
- 资助金额:
$ 4.96万 - 项目类别:
1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
1/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10026435 - 财政年份:2019
- 资助金额:
$ 4.96万 - 项目类别:
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin
基于突变工程神经球蛋白的吸入一氧化碳中毒解毒剂
- 批准号:
10660066 - 财政年份:2014
- 资助金额:
$ 4.96万 - 项目类别:
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin
基于突变工程神经球蛋白的吸入一氧化碳中毒解毒剂
- 批准号:
8801711 - 财政年份:2014
- 资助金额:
$ 4.96万 - 项目类别:
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin
基于突变工程神经球蛋白的吸入一氧化碳中毒解毒剂
- 批准号:
9389399 - 财政年份:2014
- 资助金额:
$ 4.96万 - 项目类别:
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin
基于突变工程神经球蛋白的吸入一氧化碳中毒解毒剂
- 批准号:
8974853 - 财政年份:2014
- 资助金额:
$ 4.96万 - 项目类别:
Training in Translational Research and Entrepreneurship in Pulmonary Vascular Biology
肺血管生物学转化研究和创业培训
- 批准号:
9906249 - 财政年份:2012
- 资助金额:
$ 4.96万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Red blood cell ATP export and transfusion in sepsis
脓毒症中红细胞 ATP 输出和输血
- 批准号:
10584768 - 财政年份:2023
- 资助金额:
$ 4.96万 - 项目类别:
Molecular engineering of HA-based lubricants for articular cartilage
用于关节软骨的 HA 基润滑剂的分子工程
- 批准号:
10712721 - 财政年份:2023
- 资助金额:
$ 4.96万 - 项目类别:
MLL1 drives collaborative leukocyte-endothelial cell signaling and thrombosis after coronavirus infection
MLL1在冠状病毒感染后驱动白细胞-内皮细胞信号传导和血栓形成
- 批准号:
10748433 - 财政年份:2023
- 资助金额:
$ 4.96万 - 项目类别:
FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections
FimH 靶向抗体招募分子作为预防复杂性尿路感染的新药
- 批准号:
10603693 - 财政年份:2023
- 资助金额:
$ 4.96万 - 项目类别:
Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers
用于连续监测心力衰竭生物标志物的无试剂传感器技术
- 批准号:
10636089 - 财政年份:2023
- 资助金额:
$ 4.96万 - 项目类别: